{"name":"Photocure","slug":"photocure","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2010-01-01","label":"Cysview Kit first approved","drug":"Cysview Kit","drugSlug":"5-aminolevulinic-acid-hexyl-ester","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-01-04","label":"Hexvix Phase 3 readout (Bladder Cancer)","drug":"Hexvix","drugSlug":"hexvix","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Cysview Kit","genericName":"5-aminolevulinic acid hexyl ester","slug":"5-aminolevulinic-acid-hexyl-ester","indication":"Other","status":"marketed"},{"name":"HAL 0.2% with illumination","genericName":"HAL 0.2% with illumination","slug":"hal-0-2-with-illumination","indication":"Actinic keratosis","status":"phase_2"},{"name":"Hexvix","genericName":"Hexvix","slug":"hexvix","indication":"Other","status":"discontinued"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Area cleaned with Ethyl alcohol solution","genericName":"Area cleaned with Ethyl alcohol solution","slug":"area-cleaned-with-ethyl-alcohol-solution","indication":"Disinfection and sterilization of equipment and surfaces","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"MAL","genericName":"MAL","slug":"mal","indication":"Actinic keratosis (non-hyperkeratotic, non-pigmented lesions on face and scalp)","status":"marketed"}]}],"pipeline":[{"name":"Area cleaned with Ethyl alcohol solution","genericName":"Area cleaned with Ethyl alcohol solution","slug":"area-cleaned-with-ethyl-alcohol-solution","phase":"phase_2","mechanism":"Ethyl alcohol solution is used to clean the area by denaturing proteins and disrupting cell membranes.","indications":["Disinfection and sterilization of equipment and surfaces"],"catalyst":""},{"name":"Cysview Kit","genericName":"5-aminolevulinic acid hexyl ester","slug":"5-aminolevulinic-acid-hexyl-ester","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"HAL 0.2% with illumination","genericName":"HAL 0.2% with illumination","slug":"hal-0-2-with-illumination","phase":"phase_2","mechanism":"Photodynamic therapy with aminolevulinic acid","indications":["Actinic keratosis"],"catalyst":""},{"name":"Hexvix","genericName":"Hexvix","slug":"hexvix","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MAL","genericName":"MAL","slug":"mal","phase":"marketed","mechanism":"MAL (methyl aminolevulinate) is a photosensitizing prodrug that accumulates in abnormal cells and generates reactive oxygen species when activated by red light, destroying target tissue.","indications":["Actinic keratosis (non-hyperkeratotic, non-pigmented lesions on face and scalp)","Basal cell carcinoma (superficial and nodular)","Bowen's disease (squamous cell carcinoma in situ)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5mbWxtLW9JbmFqZ09BNXI3amFxamw5Z0RVdDlyYzZVOUhURFFGTUUySnJiT1Q5RnFpR0pJTUthYjVhNF9ONF9reG1BbnMyQ0JQY2xxSXEwXzlNNzRoMzhYQ2RWR0s2RzNYMFM5NmhvMHhWcU9tV182ZmlYQmVsRFk?oc=5","date":"2026-03-25","type":"pipeline","source":"The Pharma Letter","summary":"Chinese endorsement for Cevira - The Pharma Letter","headline":"Chinese endorsement for Cevira","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNYTJia0hmYlRuZTJlUnFkTFBYek9oajBoenB0RHBteGlMRTVjclBFdS1tdWZTd0VwMFdwZERVcGhCa25saE9weGYtQ0tWbVdEYXp0TjB1Q185aExTMGVYVmFlYUNJVndwX1hWM1hxSGhMVHFOR3F3Z2dOdjdlNFFTeUFIREo4WG1UTGQ2dFJTcXV5TUgzLTgxSVNaR2xyUnpaY1c1SE9lWjhkWGhITEdQVUtzN0o0NVZmcFlmeEhlVVNJb1ZyM1R3ZjN0eHJfQ1dKUHc?oc=5","date":"2026-03-04","type":"regulatory","source":"Yicai Global","summary":"Asieris Soars as China Approves World’s First Non-Invasive Treatment for Cervical Precancerous Lesions - Yicai Global","headline":"Asieris Soars as China Approves World’s First Non-Invasive Treatment for Cervical Precancerous Lesions","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOdXNTT21lcjZsSnNHV3k3c29QcEI4UEFBMDZxWHpHRk94MjFyWjhlSmNTcG9yZ1hhWkY3WUhlWk1LRUxTSmtyVE5CbURBVWhiVFYzeWp2eEJVZl9LOWZ6QnhJLTloQVM4OHJ2U0ItOTJNTU03ZmNyQjYxMGhvX0dJOFF1S244Ui0takFHSDVaYy1iUWdhNDUtUzVIY0tHZEdpdWktVllnWExvaHNoeGM5V2RDMUd6VHZPT2FFUVlnbDVrQW1lUHdqUW1ab2VFNUdNcFlSTW1za0ZlZzExQldTb3NMNjVTY3pjdVVaY1I0dnBQQ05MRmMwVHVrYV9vTGxmblpHR0cyUC0yclNROURhQmhQdVJ4S3RZNkc5bi1LdE0wam5HNzNfdENHLWp2a1dMS0xUVmN5QTMwNUtZdnc?oc=5","date":"2026-01-30","type":"trial","source":"European Medical Journal","summary":"Recent Developments in Bacillus Calmette-Guérin-Unresponsive Non-muscle Invasive Bladder Cancer Research: The SunRISe 1 Study – Clinical Opinion - European Medical Journal","headline":"Recent Developments in Bacillus Calmette-Guérin-Unresponsive Non-muscle Invasive Bladder Cancer Research: The SunRISe 1 ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNTmI1N0hNNGlHSjZ5YkhEOTFEQXZ3M2ZIX0ZtellHZF9MemdBVEROUl9yangyVm14SmJ2cUJOdWwtMUF6OS1GT3Y4ZktXWDJkdm5uT1RDMjNaT25EcF8zeENmU1ljYzAzc2pnUEFNbVkxZ3pEeFZTZ0pLMXRjcjAyblZjRk5qdC1QRnhfZmFJcjRHbUtQaDVkXzNuMXZ3Y1hXZEctWjZZaTd0cFU2VVQzQWRXSWxKQnRxT1JKOUxpTk5FR3dITmY0cGRyN09SbkJlNTZXTVNTUnZ1QQ?oc=5","date":"2025-09-17","type":"regulatory","source":"Healio","summary":"Novel drug-releasing system generates ‘absolutely remarkable’ results for bladder cancer - Healio","headline":"Novel drug-releasing system generates ‘absolutely remarkable’ results for bladder cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOSXR4cWZMYzZEbV8wcEZBd0I5cHhrS2V6Q1F4TVFiSmtfX21JeGpZYjZ4RHZ4TFZUb0k0ZlF2bG9MbVA2eXhIeDNGSk9xWkhxcGxkazFVLUhKbTRyLXo2TV9EX09IdmVxN0lza2VOd2FvVHp6VFc5dWRfdGMtby0xWVZVMnpOWTJmU216c2NEam56Rk9vNURfclJn?oc=5","date":"2024-09-30","type":"trial","source":"The Pharma Letter","summary":"Asieris unveils positive results for Phase III trial of APL-1702 - The Pharma Letter","headline":"Asieris unveils positive results for Phase III trial of APL-1702","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1zQzRTV3JIaWhSUUhzREtoWWcyWGJDcG5OQ0otM1RDRkFVdnVCcFBzSUJoQi1tTFhtNnlYbjN2RU9XVFA1WFh0WlAtMFhQLVNHMW5kWlRRT0tqRzVlMkxJRFBlNVVBUWxhRkVuVQ?oc=5","date":"2024-06-04","type":"pipeline","source":"Biostock","summary":"News roundup Tuesday, June 4 - Biostock","headline":"News roundup Tuesday, June 4","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxQVUFpZlJzNjRlMGZXUm16WTE1MnE4UGdXX1E4Z3kyRDdpNlRvZlVxajlnYmNIc2hNOHF3ZWpFTDAwV2pSazRsQl9Xa2hJYnlWTG9OVC0zTjdrM18zWkRzczRPZGQxUTFobi12RkJPUkxTTnI1T1U5NEx3X1lSTHloekpTblVxZXQ5elhqT19vYjYzZmdYVVdhVXpaOEtqTlJRVWcyeGdjY1FVN2J2azMzcl9zajlpdFdFM0dTWlcyUjducWRJNmJqWVVHcFlJRnhubG5IOF9VOWJobHZkdVo3TElEclpVank4RWo1TkFLTzZoWEMtSXQxa3NQdUxtWENUd29pMGRkcXV5SHJxcElDMG9tS0txU25KSmw5a0FsQUFFOURwS2dZSzJCZndPOVpFNHA0ajBsMVhFelRLU3I1Q0d6bGVxWDZyNEwyZTB5QQ?oc=5","date":"2024-05-16","type":"pipeline","source":"European Medical Journal","summary":"The International Bladder Cancer Group Intermediate-Risk Non-muscle Invasive Bladder Cancer Scoring System Predicts the Need for Intervention for Patients on Active Surveillance - European Medical Jou","headline":"The International Bladder Cancer Group Intermediate-Risk Non-muscle Invasive Bladder Cancer Scoring System Predicts the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSkFVX3lxTFBfSnVYUEYwWnJ5NzFpWnlJMm1DQzlOeE1GbUllUTFRZXRUUUFzc3VSdzhKV2pCYWQxLVpiMGVrTHQzbUZvWmR3akVB?oc=5","date":"2022-07-28","type":"pipeline","source":"StockInvest.us","summary":"PHO.OL - PhotoCure ASA Company Profile - StockInvest.us","headline":"PHO.OL - PhotoCure ASA Company Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNSmxmaXBIYlFFWHR6QnpmRld6QW4zclZOVkdXNDV2MHRmWGlpcGNNdl9FSWZuaFJza0pDSzQwRmJ3c0h4eDJuU3FValZyaTNzQlpMNzJKMnBYeHJtVGg4TEpEdmJTSVA4ekEyRUJqNVE4RE1QZlphd1Fsd3NMZ3Vaa0hzUGNIcTNkQjk5aklDU1dXRXZUTkNBYkxsSFZsN2hVSWZRbUk2UThNLWw4cEFNRlhLTkNzV3dFZ3VtVC1WYnRIeWdrd1E?oc=5","date":"2020-07-01","type":"pipeline","source":"Cision News","summary":"Photocure appoints Susanne Strauss as Vice President and General Manager of Europe - Cision News","headline":"Photocure appoints Susanne Strauss as Vice President and General Manager of Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1jUkFvRUJMSXIxbENXYUt2dWZpeElyZUZRN05tZEZDbVp6eTFweVpNVXplWEV4YVl0NUFJSHh3bXg1d3ZTTXpULWZnLWlUUXA3UUlsRnlweS0yR3czclZV?oc=5","date":"2018-05-07","type":"pipeline","source":"NEJM","summary":"Hidradenitis Suppurativa - NEJM","headline":"Hidradenitis Suppurativa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOYTFZTjBHNGItS3JlMVNTN0ZQMjk0M2xmUWpYaEw5WEdTbjBZZHZNWVZEQmFnVXhxQTZzR3ppME9PcC1CQXBHRENFODhyd0RfaWZhVGs0Z2RGTzlaeU1Nc29jTF96X3VCVG15X2wwZUk1aVRzM2V3TDBYT2d1QUNJYjdqR2g5SS0wYVl1SWlSM1BUYWxKeUp2Q3AxbHQ1SmJhSkJyelAxQmF5R1pMQkdkVWNvcUVHS21XME12dFRoWjBhSk5aUThhc0hOQVZ3ZWlXMnNhXzFTSXZPT0JibGYzVFdR?oc=5","date":"2018-02-16","type":"regulatory","source":"PR Newswire","summary":"Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview® - PR Newswire","headline":"Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview®","sentiment":"positive"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":2,"marketed":2,"discontinued":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}